chr16-89918167-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The ENST00000570217.1(ENSG00000267048):​n.493G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00341 in 230,514 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0047 ( 3 hom., cov: 34)
Exomes 𝑓: 0.00087 ( 1 hom. )

Consequence

ENSG00000267048
ENST00000570217.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.96

Publications

2 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-89918167-G-A is Benign according to our data. Variant chr16-89918167-G-A is described in ClinVar as [Benign]. Clinvar id is 887813.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00471 (717/152338) while in subpopulation AFR AF = 0.0165 (686/41574). AF 95% confidence interval is 0.0155. There are 3 homozygotes in GnomAd4. There are 333 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124903759XM_047435031.1 linkc.1212+120G>A intron_variant Intron 3 of 3 XP_047290987.1
LOC124903759XM_047435032.1 linkc.*322G>A downstream_gene_variant XP_047290988.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000267048ENST00000570217.1 linkn.493G>A non_coding_transcript_exon_variant Exon 3 of 3 4
MC1RENST00000555427.1 linkc.-409+120G>A intron_variant Intron 2 of 3 5 ENSP00000451760.1 G3V4F0
MC1RENST00000639847.1 linkc.-409+120G>A intron_variant Intron 2 of 2 5 ENSP00000492011.1 Q01726

Frequencies

GnomAD3 genomes
AF:
0.00471
AC:
717
AN:
152220
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0165
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00287
GnomAD4 exome
AF:
0.000870
AC:
68
AN:
78176
Hom.:
1
Cov.:
0
AF XY:
0.000860
AC XY:
31
AN XY:
36050
show subpopulations
African (AFR)
AF:
0.0153
AC:
56
AN:
3664
American (AMR)
AF:
0.00206
AC:
5
AN:
2422
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4934
East Asian (EAS)
AF:
0.00
AC:
0
AN:
11120
South Asian (SAS)
AF:
0.00
AC:
0
AN:
672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
64
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
476
European-Non Finnish (NFE)
AF:
0.0000207
AC:
1
AN:
48314
Other (OTH)
AF:
0.000922
AC:
6
AN:
6510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00471
AC:
717
AN:
152338
Hom.:
3
Cov.:
34
AF XY:
0.00447
AC XY:
333
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0165
AC:
686
AN:
41574
American (AMR)
AF:
0.00144
AC:
22
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68020
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
38
76
114
152
190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00360
Hom.:
1
Bravo
AF:
0.00524
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.9
DANN
Benign
0.88
PhyloP100
-2.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58664942; hg19: chr16-89984575; API